Temporomandibular disorders
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
temporomandibular joint pain: at initial presentation
joint rest
Upon diagnosis, patients should be advised to begin joint rest immediately to allow the muscles of mastication to relax and reduce mandibular condyle movement.
Patients should be instructed to avoid chewing gum, biting nails, or excessive talking. Patients should be placed on a soft diet.[49]Shah A, Naqvi A. Temporomandibular disorder: a guide for general dental practitioners. Prim Dent J. 2022 Sep;11(3):118-25. http://www.ncbi.nlm.nih.gov/pubmed/36073047?tool=bestpractice.com
patient education and self-management
Treatment recommended for ALL patients in selected patient group
Educating and reassuring the patients that the condition is benign and non-progressive can be helpful.[49]Shah A, Naqvi A. Temporomandibular disorder: a guide for general dental practitioners. Prim Dent J. 2022 Sep;11(3):118-25. http://www.ncbi.nlm.nih.gov/pubmed/36073047?tool=bestpractice.com Patient information and anatomical diagrams explaining the condition and therapeutic approaches can be provided.[2]Durham J, Newton-John TR, Zakrzewska JM. Temporomandibular disorders. BMJ. 2015 Mar 12;350:h1154. http://www.ncbi.nlm.nih.gov/pubmed/25767130?tool=bestpractice.com [49]Shah A, Naqvi A. Temporomandibular disorder: a guide for general dental practitioners. Prim Dent J. 2022 Sep;11(3):118-25. http://www.ncbi.nlm.nih.gov/pubmed/36073047?tool=bestpractice.com BMJ Best Practice: patient information - temporomandibular disorders Opens in new window
physiotherapy
Additional treatment recommended for SOME patients in selected patient group
Physiotherapy may be useful if provided by a specialist TMD physiotherapist. Interventions such as manual therapy, exercise, electrophysiological modalities (such as ultrasound, transcutaneous electrical nerve stimulation, or laser), and neuromuscular re-education have been found to be helpful.[74]Fisch G, Finke A, Ragonese J, et al. Outcomes of physical therapy in patients with temporomandibular disorder: a retrospective review. Br J Oral Maxillofac Surg. 2021 Feb;59(2):145-50. http://www.ncbi.nlm.nih.gov/pubmed/33280944?tool=bestpractice.com Significant improvement in maximum mouth opening and reduction in pain were reported in patients with TMDs who underwent physiotherapy.[54]Arribas-Pascual M, Hernández-Hernández S, Jiménez-Arranz C, et al. Effects of physiotherapy on pain and mouth opening in temporomandibular disorders: an umbrella and mapping systematic review with meta-meta-analysis. J Clin Med. 2023 Jan 18;12(3):788. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917698 http://www.ncbi.nlm.nih.gov/pubmed/36769437?tool=bestpractice.com [74]Fisch G, Finke A, Ragonese J, et al. Outcomes of physical therapy in patients with temporomandibular disorder: a retrospective review. Br J Oral Maxillofac Surg. 2021 Feb;59(2):145-50. http://www.ncbi.nlm.nih.gov/pubmed/33280944?tool=bestpractice.com
splints and/or bite guards
Additional treatment recommended for SOME patients in selected patient group
If symptoms do not improve after 2 weeks’ joint rest, patients may be referred to their dental practitioner to construct an oral splint. These should cover the whole of the occlusal surface of one arch. Some studies indicate that hard stabilisation appliances may be more effective in reducing temporomandibular joint pain than soft stabilisation appliances.[55]Fricton J, Look JO, Wright E, et al. Systematic review and meta-analysis of randomized controlled trials evaluating intraoral orthopedic appliances for temporomandibular disorders. J Orofac Pain. 2010;24:237-54. http://www.ncbi.nlm.nih.gov/pubmed/20664825?tool=bestpractice.com Splints may help in relieving muscle spasm, offloading the joints, and changing the oral habits of patients that may contribute to TMDs.
Evidence for the efficacy of splints is mixed and of low certainty. One systematic review indicated that splints are useful in reducing pain but not in improving masticatory function.[56]Ebrahim S, Montoya L, Busse JW, et al. The effectiveness of splint therapy in patients with temporomandibular disorders: a systematic review and meta-analysis. J Am Dent Assoc. 2012;143:847-57. http://www.ncbi.nlm.nih.gov/pubmed/22855899?tool=bestpractice.com Another systematic review concluded that occlusive splint therapy, alone or in combination with other treatment modalities, effectively reduced pain.[57]Tournavitis A, Sandris E, Theocharidou A, et al. Effectiveness of conservative therapeutic modalities for temporomandibular disorders-related pain: a systematic review. Acta Odontol Scand. 2023 May;81(4):286-97. http://www.ncbi.nlm.nih.gov/pubmed/36354093?tool=bestpractice.com However, one rapid review concluded that occlusal splint therapy was not recommended for the management of TMDs owing to lack of conclusive evidence.[58]Tran C, Ghahreman K, Huppa C, et al. Management of temporomandibular disorders: a rapid review of systematic reviews and guidelines. Int J Oral Maxillofac Surg. 2022 Sep;51(9):1211-25. http://www.ncbi.nlm.nih.gov/pubmed/35339331?tool=bestpractice.com Another systematic review found that evidence supporting the effectiveness of oral splints for the management of patients with TMDs and bruxism was of low certainty.[59]Riley P, Glenny AM, Worthington HV, et al. Oral splints for temporomandibular disorder or bruxism: a systematic review. Br Dent J. 2020 Feb;228(3):191-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718146 http://www.ncbi.nlm.nih.gov/pubmed/32060462?tool=bestpractice.com Irreversible oral splints are not recommended.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227. https://www.bmj.com/content/383/bmj-2023-076227.long http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com [51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226. https://www.bmj.com/content/383/bmj-2023-076226.long http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
stress management
Additional treatment recommended for SOME patients in selected patient group
Patients should be counselled to reduce stress.[49]Shah A, Naqvi A. Temporomandibular disorder: a guide for general dental practitioners. Prim Dent J. 2022 Sep;11(3):118-25. http://www.ncbi.nlm.nih.gov/pubmed/36073047?tool=bestpractice.com
Stress may lead to para-functional habits like bruxism or clenching.
Relaxation techniques such as diaphragmatic breathing may be beneficial.[2]Durham J, Newton-John TR, Zakrzewska JM. Temporomandibular disorders. BMJ. 2015 Mar 12;350:h1154. http://www.ncbi.nlm.nih.gov/pubmed/25767130?tool=bestpractice.com Advise patients to massage the areas of spasm for 1 minute, four times per day.
cognitive behavioural therapy (CBT)
Additional treatment recommended for SOME patients in selected patient group
CBT aims to teach patients how to cope up with their pain. In one randomised controlled trial, CBT reduced pain and disability to the same extent as occlusal splint therapy, but it was more effective at improving patient pain-coping skills.[52]Shedden Mora MC, Weber D, Neff A, et al. Biofeedback-based cognitive-behavioral treatment compared with occlusal splint for temporomandibular disorder: a randomized controlled trial. Clin J Pain. 2013;29:1057-65. http://www.ncbi.nlm.nih.gov/pubmed/23446073?tool=bestpractice.com One systematic review found that CBT was slightly better than alternative treatments in reducing pain intensity or psychological distress. However, the evidence was of low or very low certainty.[53]Penlington C, Bowes C, Taylor G, et al. Psychological therapies for temporomandibular disorders (TMDs). Cochrane Database Syst Rev. 2022 Aug 11;(8):CD013515. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013515.pub2/full http://www.ncbi.nlm.nih.gov/pubmed/35951347?tool=bestpractice.com
muscle relaxant
Additional treatment recommended for SOME patients in selected patient group
Muscle relaxants act by reducing muscle hyperactivity and relieving muscle-related symptoms, and are typically used at initial presentation for up to 2 weeks.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78. https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8 http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com These drugs may be used in patients in whom non-pharmacological interventions do not provide relief. Benzodiazepines (e.g., diazepam), if used, must be limited to the initial treatment phase only (up to 2 weeks).[64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86. https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com
Benzodiazepines are associated with misuse, abuse, and addiction, and should only be prescribed under the guidance of a pain management clinician.
If TMD symptoms are muscle related, cyclobenzaprine may be prescribed.[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7. https://jcda.ca/h7 http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com [64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86. https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com [65]Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Front. Oral Maxillofac. Med. 2022 Jun 10;4:17. https://fomm.amegroups.org/article/view/52991/html#B10 Cyclobenzaprine is structurally related to benzodiazepines. It is contraindicated in patients with hyperthyroidism, congestive heart failure, arrhythmias, and recent heart attacks.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78. https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8 http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com
Primary options
diazepam: 2-10 mg orally three to four times daily
OR
cyclobenzaprine: 5-10 mg orally (immediate-release) once daily at bedtime
persistent pain after 2 weeks of joint rest and <3 months of duration
non-steroidal anti-inflammatory drug (NSAID)
NSAIDs are most frequently used for acute TMD.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78. https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8 http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com [61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7. https://jcda.ca/h7 http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com Oral NSAIDs may be helpful to relieve pain, and can relieve pain and inflammation in patients with osteoarthritis or internal derangement.[62]Kulkarni S, Thambar S, Arora H. Evaluating the effectiveness of nonsteroidal anti-inflammatory drug(s) for relief of pain associated with temporomandibular joint disorders: a systematic review. Clin Exp Dent Res. 2020 Feb;6(1):134-46. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025987 http://www.ncbi.nlm.nih.gov/pubmed/32067407?tool=bestpractice.com [63]Montinaro F, Nucci L, d'Apuzzo F, et al. Oral nonsteroidal anti-inflammatory drugs as treatment of joint and muscle pain in temporomandibular disorders: a systematic review. Cranio. 2022 Feb 7:1-10. http://www.ncbi.nlm.nih.gov/pubmed/35129419?tool=bestpractice.com Topical NSAIDs (e.g., diclofenac) can be applied over the temporomandibular joint to alleviate joint pain. One systematic review reported reduction in pain and improved range of motion with NSAIDs, but a consensus could not be reached because of heterogeneity.[62]Kulkarni S, Thambar S, Arora H. Evaluating the effectiveness of nonsteroidal anti-inflammatory drug(s) for relief of pain associated with temporomandibular joint disorders: a systematic review. Clin Exp Dent Res. 2020 Feb;6(1):134-46. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025987 http://www.ncbi.nlm.nih.gov/pubmed/32067407?tool=bestpractice.com Topical NSAIDs may be preferred because limited evidence suggests they are as effective as oral NSAIDs, but do not cause gastrointestinal side effects.[62]Kulkarni S, Thambar S, Arora H. Evaluating the effectiveness of nonsteroidal anti-inflammatory drug(s) for relief of pain associated with temporomandibular joint disorders: a systematic review. Clin Exp Dent Res. 2020 Feb;6(1):134-46. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025987 http://www.ncbi.nlm.nih.gov/pubmed/32067407?tool=bestpractice.com
NSAIDs inhibit platelet aggregation and cause gastric irritation when used orally. There is also a risk of hepatotoxicity and nephrotoxicity. Use caution when prescribing to patients with bleeding disorders, or to those with kidney or liver disorders.
Use the lowest effective dose for the shortest treatment duration (e.g., up to 14 days treatment may be required for this indication).
Primary options
diclofenac topical: (1% gel) apply 2 g to the affected area(s) four times daily when required, maximum 8 g/joint/day (upper extremity joints) or 32 g/day total
Secondary options
ibuprofen: 400 mg orally every 4-6 hours when required, maximum 2400 mg/day
OR
naproxen: 250-500 mg orally twice daily when required, maximum 1250 mg/day
OR
diclofenac potassium: 50 mg orally (immediate-release) three times daily when required, maximum 150 mg/day
chronic pain ≥3 months
non-pharmacological therapies
Effective non-pharmacological interventions to manage chronic pain (≥3 months) include: cognitive behavioural therapy (CBT) augmented with biofeedback or relaxation therapy, therapist-assisted jaw mobilisation, and manual trigger point therapy. One systematic review and network meta-analysis found that CBT with or without biofeedback or relaxation therapy, therapist-assisted jaw mobilisation, and manual trigger point therapy are the most effective interventions to manage chronic TMD pain.[51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226. https://www.bmj.com/content/383/bmj-2023-076226.long http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
Other interventions that are less effective but still can be used include: supervised postural exercises, supervised jaw exercises and stretching, supervised jaw exercises and stretching with manual trigger point therapy, and usual care (such as education, support, home exercises, and stretching).[51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226. https://www.bmj.com/content/383/bmj-2023-076226.long http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
CBT aims to teach patients how to cope up with their pain. With or without biofeedback or relaxation therapy, CBT is the ideal psychological treatment for managing chronic pain.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227. https://www.bmj.com/content/383/bmj-2023-076227.long http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com [50]Molin C. From bite to mind: TMD - a personal and literature review. Int J Prosthodont. 1999;12:279-88. http://www.ncbi.nlm.nih.gov/pubmed/10635197?tool=bestpractice.com [51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226. https://www.bmj.com/content/383/bmj-2023-076226.long http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
The tight and sensitive muscles around the jaw, known as trigger points, are the primary reason for TMD pain. Pain associated with trigger points can be relieved by manual therapy, wherein a physiotherapist applies targeted pressure with hands to promote circulation in affected areas. This helps release muscle knots and provides relief from pain.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227. https://www.bmj.com/content/383/bmj-2023-076227.long http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com [51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226. https://www.bmj.com/content/383/bmj-2023-076226.long http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
low-dose antidepressant or anticonvulsant or opioid
Additional treatment recommended for SOME patients in selected patient group
Pharmacological therapy may be prescribed if non-pharmacological interventions alone do not provide relief.
Low-dose tricyclic antidepressants (e.g., amitriptyline) may aid in the management of chronic TMD pain (>3 months duration).[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7. https://jcda.ca/h7 http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com [64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86. https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com [66]Rizzatti-Barbosa CM, Nogueira MT, de Andrade ED, et al. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders. Cranio. 2003 Jul;21(3):221-5. http://www.ncbi.nlm.nih.gov/pubmed/12889679?tool=bestpractice.com One randomised controlled clinical trial found that low doses of amitriptyline reduced orofacial pain due to TMD.[67]de Sousa BM, López-Valverde A, Caramelo F, et al. Use of antidepressants in the treatment of chronic orofacial pain caused by temporomandibular disorders: a randomized controlled clinical trial. [in spa]. Med Clin (Barc). 2024 Jul 26;163(2):74-7. http://www.ncbi.nlm.nih.gov/pubmed/38570297?tool=bestpractice.com [68]ClinicalTrials.gov. Myofascial pain patients' response to the administration of low doses of amitriptyline and citalopram compared with the use of bite splint. ClinicalTrials.gov Identifier: NCT04777838. Mar 2021 [internet publication]. https://clinicaltrials.gov/study/NCT04777838 Adverse effects of tricyclic antidepressants include sedation, dizziness, blurred vision, constipation, cardiac complications, and xerostomia.[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7. https://jcda.ca/h7 http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com [65]Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Front. Oral Maxillofac. Med. 2022 Jun 10;4:17. https://fomm.amegroups.org/article/view/52991/html#B10 Caution should be exercised when using these drugs in older patients and in those with cardiac conditions.
Anticonvulsants (e.g., gabapentin, pregabalin) may be prescribed to patients in whom temporomandibular joint surgery has failed or to those with persistent/chronic pain (>3 months duration).[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7. https://jcda.ca/h7 http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com [64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86. https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com [70]Kimos P, Biggs C, Mah J, et al. Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial. Pain. 2007 Jan;127(1-2):151-60. http://www.ncbi.nlm.nih.gov/pubmed/17030096?tool=bestpractice.com
Opioids are drugs of last choice and should be avoided unless under the guidance of a pain physician. Opioid analgesics can effectively reduce pain and have been used in dentistry to manage moderate to severe pain. Opioids are generally not recommended in TMDs, and their use should be restricted for patients with chronic pain (>3 months duration) in whom non-opioid therapies are ineffective.[64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86. https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com Opioids (e.g., codeine, oxycodone) may be prescribed for short-term management of severe TMD pain.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78. https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8 http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com Hydromorphone may be used for severe intractable pain.[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7. https://jcda.ca/h7 http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com [65]Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Front. Oral Maxillofac. Med. 2022 Jun 10;4:17. https://fomm.amegroups.org/article/view/52991/html#B10 Long-term use for chronic pain management is discouraged as it can result in addiction and/or overdose.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227. https://www.bmj.com/content/383/bmj-2023-076227.long http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com [51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226. https://www.bmj.com/content/383/bmj-2023-076226.long http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com [61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7. https://jcda.ca/h7 http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com [65]Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Front. Oral Maxillofac. Med. 2022 Jun 10;4:17. https://fomm.amegroups.org/article/view/52991/html#B10 Fentanyl transdermal patches can be used as an alternative to the oral route.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78. https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8 http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com
Primary options
amitriptyline: 10-25 mg orally once daily at bedtime initially, increase gradually according to response, maximum 150 mg/day
OR
gabapentin: 300 mg orally once daily for 1 day, followed by 300 mg twice daily for 1 day, then 300 mg three times daily, increase gradually according to response, maximum 3600 mg/day
OR
pregabalin: 50 mg orally (immediate-release) three times daily initially, increase gradually according to response, maximum 600 mg/day
Secondary options
codeine phosphate: 30-60 mg orally every 6 hours when required, maximum 240 mg/day
OR
oxycodone: 5-15 mg orally (immediate-release) every 4-6 hours when required, adjust dose according to response
OR
hydromorphone: 2-4 mg orally (immediate-release) every 4-6 hours when required, adjust dose according to response
OR
fentanyl transdermal: dose depends on current opioid intake; consult specialist for guidance on dose
refractory pain or disability: osteoarthritis or internal derangement subtype
consider surgery
Refer to an appropriately trained maxillofacial surgeon following a period of failed conservative management with persistent joint pain, limited mouth opening (<35 mm), or frequent locking.
Surgical procedures include a stepwise ladder approach from arthrocentesis and arthroscopy, open surgery, and even total alloplastic temporomandibular joint replacement, which have good long-term outcomes.[58]Tran C, Ghahreman K, Huppa C, et al. Management of temporomandibular disorders: a rapid review of systematic reviews and guidelines. Int J Oral Maxillofac Surg. 2022 Sep;51(9):1211-25. http://www.ncbi.nlm.nih.gov/pubmed/35339331?tool=bestpractice.com [71]Sidebottom AJ, Salha R. Management of the temporomandibular joint in rheumatoid disorders. Br J Oral Maxillofac Surg. 2013 Apr;51(3):191-8. http://www.ncbi.nlm.nih.gov/pubmed/22658606?tool=bestpractice.com [72]National Institute for Health and Care Excellence. Total prosthetic replacement of the temporomandibular joint. Aug 2014 [internet publication]. https://www.nice.org.uk/guidance/ipg500 Recurrent dislocation should be referred to an appropriately trained maxillofacial surgeon.
Surgery is reserved for patients with moderate to severe pain, notable pathology, or recurrent dislocation and those who are disabled by their condition.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer